This product is mainly composed of ulinastatin, a kind of glycoprotein
extracted from fresh human urine that can inhibit the activity of various
proteolytic enzymes. It belongs to protease inhibitor.
Ulinastatin character
This product is white to yellowish freeze-dried lump or powder. After
reconstitution, it shall be a clear liquid, colorless to yellow, with slight
opalescence.
The indication for ulinastatin
1. Acute pancreatitis;
Chronic recurrent pancreatitis; 3.
3. Rescue adjuvant medication for acute circulatory failure.
Ulinastatin specification
(15) 50,000 units; (2) 100,000 units.
Usage and dosage of ulinastatin
1. Acute pancreatitis and chronic recurrent pancreatitis: at the initial
stage, 1000 units were dissolved in 500ml 5% glucose injection or sodium
chloride injection intravenously for 1 to 2 hours each time, 1 to 3 times a day,
and the dosage was reduced as the symptoms subsided;
2. Acute circulative failure, 100,000 units each time dissolved in 500mL 5%
glucose injection or sodium chloride injection intravenous infusion, each time
static drip for 1-2 hours, 1-3 times a day, or 100,000 units each time dissolved
in 5-10ml sodium chloride injection, slowly intravenous injection for 1-3 times
a day. And can be based on age, symptoms appropriate increase or decrease.
Ulinastatin storage
Keep in a sealed, cool and dry place (no more than 20℃).